|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0813 | ED149100 | General Research Use | No | Female | White | 59 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1328 | ED149468 | General Research Use | No | Female | White | 58 | 5 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1584 | ED148760 | General Research Use | No | Female | White | 59 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2039 | ED148729 | General Research Use | No | Female | White | 57 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2139 | ED149406 | General Research Use | No | Male | White | 55 | 7 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2562 | ED148827 | General Research Use | No | Female | White | 56 | 8 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2903 | ED148243 | General Research Use | No | Male | White | 57 | 6 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3026 | ED149078 | General Research Use | No | Male | White | 56 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_0274 | ED149668 | General Research Use | No | Female | White | 58 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0294 | ED148943 | General Research Use | No | Female | White | 55 | 8 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0363 | ED148374 | General Research Use | No | Male | White | 57 | 5 - AREDS AMD Severity Scale Step 5 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_1115 | ED148382 | General Research Use | No | Female | White | 59 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1123 | ED148492 | General Research Use | No | Male | White | 56 | 7 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1150 | ED149263 | General Research Use | No | Female | White | 55 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_1320 | ED148160 | General Research Use | No | Male | White | 59 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1611 | ED149237 | General Research Use | No | Female | White | 59 | 6 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2180 | ED149349 | General Research Use | No | Male | White | 55 | 10 - Central GA | 10 - Central GA |
| AR2_2334 | ED149448 | General Research Use | No | Male | White | 58 | 6 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_3388 | ED149821 | General Research Use | No | Female | White | 57 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_3495 | ED148282 | General Research Use | No | Male | White | 56 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |